- Previous Close
0.0140 - Open
0.0140 - Bid 0.0140 x --
- Ask 0.0150 x --
- Day's Range
0.0140 - 0.0140 - 52 Week Range
0.0010 - 0.0180 - Volume
250 - Avg. Volume
44,828 - Market Cap (intraday)
240,183 - Beta (5Y Monthly) 2.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Feb 13, 2025 - Feb 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
www.lobesciences.comRecent News: LOBEF
View More
Performance Overview: LOBEF
Trailing total returns as of 11/18/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LOBEF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LOBEF
View MoreValuation Measures
Market Cap
2.44M
Enterprise Value
3.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.48
Price/Book (mrq)
--
Enterprise Value/Revenue
5.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-62.09%
Return on Equity (ttm)
-4,833.77%
Revenue (ttm)
976.74k
Net Income Avi to Common (ttm)
-2.97M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
40.99k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.7M
Company Insights: LOBEF
LOBEF does not have Company Insights